My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 212

    1.

    Glycemic actions of alanine and terbutaline in IDDM.

    Wiethop BV, Cryer PE.

    Diabetes Care. 1993 Aug;16(8):1124-30.PMID: 8375242 [PubMed - indexed for MEDLINE]Related articles

    2.

    Alanine and terbutaline in treatment of hypoglycemia in IDDM.

    Wiethop BV, Cryer PE.

    Diabetes Care. 1993 Aug;16(8):1131-6.PMID: 8375243 [PubMed - indexed for MEDLINE]Related articles

    3.

    Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.

    Pampanelli S, Torlone E, Ialli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB.

    Diabetes Care. 1995 Nov;18(11):1452-9.PMID: 8722069 [PubMed - indexed for MEDLINE]Related articles

    4.

    Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epinephrine in humans.

    Berk MA, Clutter WE, Skor D, Shah SD, Gingerich RP, Parvin CA, Cryer PE.

    J Clin Invest. 1985 Jun;75(6):1842-51.PMID: 3891786 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM.

    Saleh TY, Cryer PE.

    Diabetes Care. 1997 Aug;20(8):1231-6.PMID: 9250445 [PubMed - indexed for MEDLINE]Related articles

    6.

    Loss of potentiating effect of hypoglycemia on the glucagon response to hyperaminoacidemia in IDDM.

    Caprio S, Tamborlane WV, Zych K, Gerow K, Sherwin RS.

    Diabetes. 1993 Apr;42(4):550-5.PMID: 8454105 [PubMed - indexed for MEDLINE]Related articles

    7.

    Hypoglycemia-induced autonomic failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation.

    Rattarasarn C, Dagogo-Jack S, Zachwieja JJ, Cryer PE.

    Diabetes. 1994 Jun;43(6):809-18.PMID: 8194668 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM.

    Levy CJ, Kinsley BT, Bajaj M, Simonson DC.

    Diabetes Care. 1998 Aug;21(8):1330-8.PMID: 9702443 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people.

    Rossetti P, Porcellati F, Busciantella Ricci N, Candeloro P, Cioli P, Nair KS, Santeusanio F, Bolli GB, Fanelli CG.

    Diabetes. 2008 Jul;57(7):1905-17. Epub 2008 Apr 4.PMID: 18390791 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM.

    Dagogo-Jack S, Rattarasarn C, Cryer PE.

    Diabetes. 1994 Dec;43(12):1426-34.PMID: 7958494 [PubMed - indexed for MEDLINE]Related articles

    11.

    Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.

    Dagogo-Jack SE, Craft S, Cryer PE.

    J Clin Invest. 1993 Mar;91(3):819-28.PMID: 8450063 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Failure of nocturnal hypoglycemia to cause daytime hyperglycemia in patients with IDDM.

    Hirsch IB, Smith LJ, Havlin CE, Shah SD, Clutter WE, Cryer PE.

    Diabetes Care. 1990 Feb;13(2):133-42.PMID: 2190769 [PubMed - indexed for MEDLINE]Related articles

    13.

    Defective activation of skeletal muscle and adipose tissue lipolysis in type 1 diabetes mellitus during hypoglycemia.

    Enoksson S, Caprio SK, Rife F, Shulman GI, Tamborlane WV, Sherwin RS.

    J Clin Endocrinol Metab. 2003 Apr;88(4):1503-11.PMID: 12679430 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.

    Popp DA, Shah SD, Cryer PE.

    J Clin Invest. 1982 Feb;69(2):315-26.PMID: 6120181 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.

    Creutzfeldt WO, Kleine N, Willms B, Orskov C, Holst JJ, Nauck MA.

    Diabetes Care. 1996 Jun;19(6):580-6.PMID: 8725855 [PubMed - indexed for MEDLINE]Related articles

    16.

    Glucagon, not insulin, may play a secondary role in defense against hypoglycemia during exercise.

    Tuttle KR, Marker JC, Dalsky GP, Schwartz NS, Shah SD, Clutter WE, Holloszy JO, Cryer PE.

    Am J Physiol. 1988 Jun;254(6 Pt 1):E713-9.PMID: 3287952 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM.

    Torlone E, Pampanelli S, Lalli C, Del Sindaco P, Di Vincenzo A, Rambotti AM, Modarelli F, Epifano L, Kassi G, Perriello G, Brunetti P, Bolli G.

    Diabetes Care. 1996 Sep;19(9):945-52.PMID: 8875087 [PubMed - indexed for MEDLINE]Related articles

    18.

    Insulin regulation of lipolysis in nondiabetic and IDDM subjects.

    Jensen MD, Caruso M, Heiling V, Miles JM.

    Diabetes. 1989 Dec;38(12):1595-601.PMID: 2573554 [PubMed - indexed for MEDLINE]Related articles

    19.

    Alcohol intake impairs glucose counterregulation during acute insulin-induced hypoglycemia in IDDM patients. Evidence for a critical role of free fatty acids.

    Avogaro A, Beltramello P, Gnudi L, Maran A, Valerio A, Miola M, Marin N, Crepaldi C, Confortin L, Costa F, et al.

    Diabetes. 1993 Nov;42(11):1626-34.PMID: 8405705 [PubMed - indexed for MEDLINE]Related articles

    20.

    Differences between prebreakfast and late afternoon glycemic responses to exercise in IDDM patients.

    Ruegemer JJ, Squires RW, Marsh HM, Haymond MW, Cryer PE, Rizza RA, Miles JM.

    Diabetes Care. 1990 Feb;13(2):104-10.PMID: 2190767 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity